In vitro and in vivo experiments on CEA were made with a cell strain (C-1) which was derived from a cancer of the colon and established in the Department of Surgery, Tokyo Medical College, and serum levels of CEA were also evaluated in 140 patients with cancer of the lung.
The level of CEA was seen to be low both in vitro and in vivo at the time when the number of tumor cells or the weight of tumors was rapidly increasing and to be remarkably high at the time when the number of cells or the weight of tumors became slower in increase or tended to decrease.
When db-cAMP or MMC was added to cultures of C-1 cells, the growth of cells was inhibited and the level of CEA was remarkably high only in the db-cAMP group: A significantly high level of CEA was observed also in 3 kinds of other cell strains which were established from well differentiated adenocarcinoma. From the results stated above, it was seen that the inhibited growth and the differentiation of tumor cells had a close relation to a high level of CEA.
The weight of tumors increased in proportion to the level of CEA, but the level of CEA could not clinically be correlated with the volume of tumors, because the tumor did not metastasize to nude mice in vitro. On the other hand, the clinical course, the extent of lymphatic metastasis, the presence or absence of remote metastasis, and the presence or absence of tumor cells in the blood vessel of the lung were proportional to the blood level of CEA.
From these results, the blood level of CEA is considered to be dependent on the biological properties and the total amount of tumor cells in a carrier of cancer.
View full abstract